Evidence map›Paper›PMID 37724881›Full record

ArticleJournal of virology2023

Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to

Shigeru Fujita, Yusuke Kosugi, Izumi Kimura, Kenzo Tokunaga, Genotype to Phenotype Japan (G2P-Japan) Consortium, Jumpei Ito, Kei Sato

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 10 institutions in 1 country.

Shigeru Fujita *Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
Yusuke Kosugi *Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
Izumi KimuraDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
Kenzo TokunagaDepartment of Pathology, National Institute of Infectious Diseases , Tokyo, Japan.
Genotype to Phenotype Japan (G2P-Japan) Consortium
Jumpei ItoDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.
Kei SatoDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan.ORCID 0000-0003-4431-1380
Kyoto University · JPHokkaido University · JPKumamoto University · JPTokyo Metropolitan Institute of Public Health · JPThe University of Tokyo · JPUniversity of Miyazaki · JPNational Institute of Infectious Diseases · JPHiroshima University · JPKyushu University · JPTokai University · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP21fk0108425Japan Agency for Medical Research and Development (AMED) JP21fk0108432Japan Agency for Medical Research and Development (AMED) JP21fk0108494Japan Agency for Medical Research and Development (AMED) JP223fa627001Japan Agency for Medical Research and Development (AMED) JP223fa727002Japan Agency for Medical Research and Development (AMED) JP22fk0108146Japan Agency for Medical Research and Development (AMED) JP22fk0108506Japan Agency for Medical Research and Development (AMED) JP22fk0108511Japan Agency for Medical Research and Development (AMED) JP22fk0108516Japan Agency for Medical Research and Development (AMED) JP22fk0410039Japan Science an Technology Agency (JST) CREST JPMJCR20H4Japan Science an Technology Agency (JST) PRESTO JPMJPR22R1Japan Science an Technology Agency (JST) SPRING JPMJSP2108Japan Society for the Promotion of Science (JSPS) JPJSCCA20190008Japan Society for the Promotion of Science (JSPS) KAKENHI 20K15767Japan Society for the Promotion of Science (JSPS) KAKENHI 23K14526
6 · The paper itself

Abstract

importanceThe efficiency of infection receptor use is the first step in determining the species tropism of viruses. After the coronavirus disease 2019 pandemic, a number of SARS-CoV-2-related coronaviruses (SC2r-CoVs) were identified in

Indexed as

Angiotensin-Converting Enzyme 2ChiropteraSARS-CoV-2AnimalsCOVID-19HumansPhylogenySpike Glycoprotein, CoronavirusTropismACE2 protein, humanAngiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2ACE2coronavirusRhinolophus batSARS-CoV-2spike

Identifiers

PMID37724881
PMCPMC10779674
OpenAlexW4386844903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.